The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation
- 28 February 1997
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 25 (2) , 271-276
- https://doi.org/10.1016/s0741-5214(97)70348-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Arg506GIn Factor V Mutation (Factor V Leiden) in Patients with Ischaemic Cerebrovascular Disease and Survivors of Myocardial InfarctionThrombosis and Haemostasis, 1995
- Ischemic Stroke in Young Patients With Activated Protein C ResistanceStroke, 1995
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Modified APC resistance assay for patients on oral anticoagulantsThe Lancet, 1994
- Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient familiesBlood, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Arterial and venous thromboembolism with fatal outcome and resistance to activated protein CThe Lancet, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjectsBlood Coagulation & Fibrinolysis, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993